Document is current
Any future updates will be listed below
-
Authors
Hutchinson, Kelly Ann https://orcid.org/0000-0003-0619-3512
Baxter, Stephanie
Mollan, Susan https://orcid.org/0000-0002-6314-4437
- License Information
-
More Information
Article History
Received: 18 January 2026
Revised: 4 February 2026
Accepted: 12 February 2026
First Online: 20 February 2026
Competing interests
: SM reports consultancy fees (Invex Therapeutics); advisory board fees (Ocular Therapeutix, Dompé Farmaceutici); speaker fees (Teva); Travel (AbbVie, EssilorLuxottica and European Alliance of Associations for Rheumatology); Receipt of equipment (Heidelberg Engineering). SM is a member of the Eye editorial board. The other authors declare no potential conflicts of interest.
: Informed written consent was obtained from the patient for the publication of this case and images.
